New to Meducation?
Sign up
Already signed up? Log In
view moderators

MedicalOncology

Category

7
1
38

Interview with Dr. Kristin Manning, Part 2: Challenges in Cancer Imaging (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.</span></p>  
Howard (Jack) West, MD
about 9 years ago
8
1
33

Interview with Dr. Kristin Manning, Part 2: Challenges in Cancer Imaging (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.</span></p>  
Howard (Jack) West, MD
about 9 years ago
9
1
56

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
about 9 years ago
10
1
52

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
about 9 years ago
11
1
66

IInterview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
about 9 years ago
12
1
46

Interview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
about 9 years ago
13
1
23

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (audio)

<p><span style="font-family: Times; font-size: medium;"> </span></p <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;"><span style="font-family: Times; font-size: medium; white-space: normal;"> </span></span></span></p <span style="font-family: arial, sans, sans-serif; font-size: small;" <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></span></p </div </span <p>&nbsp;</p </div <p>&nbsp;</p>  
Howard (Jack) West, MD
about 9 years ago
0
1
29

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></p>  
Howard (Jack) West, MD
about 9 years ago
1
1
62

Interview with Dr. Matthew Horton, Pathologist Part 2: Neuroendocrine Lung Tumors and Bronchioloalveolar Carcinoma (audio)

<p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: Times; font-size: medium; white-space: normal;" <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: arial, sans, sans-serif; font-size: 13px;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).</span></span></font></p </div </span></span></font></p>  
Howard (Jack) West, MD
about 9 years ago
2
1
74

Interview with Dr. Matthew Horton, Pathologist Part 2: Neuroendocrine Lung Tumors and Bronchioloalveolar Carcinoma (video)

<p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: arial, sans, sans-serif; font-size: 13px;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).</span></span></font></p>  
Howard (Jack) West, MD
about 9 years ago
3
0
144

Interview with Dr. Matthew Horton, Pathologist Part 1: Basics of Non-Small Cell Lung Cancer Subtypes (audio)

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the basic subtypes of non-small cell lung cancer (NSCLC), methods of interpreting NSCLC histology, and the changing importance of pathology in NSCLC management.  
Howard (Jack) West, MD
about 9 years ago
4
1
85

Interview with Dr. Matthew Horton, Pathologist Part 1: Basics of Non-Small Cell Lung Cancer Subtypes (video)

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the basic subtypes of non-small cell lung cancer (NSCLC), methods of interpreting NSCLC histology, and the changing importance of pathology in NSCLC management.  
Howard (Jack) West, MD
about 9 years ago
5
1
27

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
about 9 years ago
6
1
20

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
about 9 years ago
7
1
27

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
about 9 years ago
8
1
21

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
about 9 years ago
9
1
62

Second Line Treatment of Adv NSCLC: What Drugs and When? (audio)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
about 9 years ago
10
1
70

Second Line Treatment of Adv NSCLC: What Drugs and When? (video)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
about 9 years ago
13
1
38

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (audio)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
about 9 years ago
0
1
34

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (video)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
about 9 years ago